Medical Imaging Technology for Oncology Diagnostics

May 05, 2011

Wellesley, Mass. – According to a new technical market research report, MEDICAL IMAGING TECHNOLOGY FOR ONCOLOGY DIAGNOSTICS (HLC074A) from BCC Research (www.bccresearch.com), the global market value of medical imaging technology for oncology diagnostics was an estimated $11.6 billion in 2010, but is expected to increase to more than $14.8 billion in 2015, for a 5-year compound annual growth rate (CAGR) of 5%.

The largest segment of the market, made up of various X-ray systems, is projected to grow at a CAGR of 4.9% to reach $3.3 billion in 2015. Its value was estimated at more than $1 billion in 2010.

The second-largest segment, computer tomography (CT), was estimated at nearly $2.5 billion in 2010, and is expected to increase at a 5-year CAGR of 5.2% to reach nearly $3.2 billion in 2015.

The ultrasound segment is projected to have a 5-year CAGR of 6.2%, rising from $1.9 billion in 2010 to nearly $2.6 billion in 2015.

The endoscopy segment is expected to grow from $1.6 billion in 2010 to nearly $1.8 billion in 2015 at a CAGR of only 1.8%.

Other systems in the report for which data is reported are MRI, PACS (picture archiving and communications systems, which have the highest projected 5-year CAGR in this group at 6.8%), PET/CT, and SPECT (single photon emission computed tomography).

Oncology diagnostic imaging products designate hardware, software, and supplies used to create, view, and manage visual images of nonvisible organs of the human body for purposes of diagnosing cancer. The report focuses on end-user markets, including hospitals, freestanding clinics, doctors’ offices, and equipment leasing companies.

New and emerging technologies that may become commercially significant by 2015 are also addressed in this report. These include contrast-enhanced ultrasound, subharmonic breast ultrasound, whole-breast ultrasound tomography, radiation luminescence and radioactive optical nano-imaging techniques, near-infrared fluorescent imaging, near-infrared (NIR) optical coherence tomography, supersonic shear imaging (SSI), microwave tomography, cone beam CT, digital breast tomosynthesis (DBT), single-shot spectral imaging (SSSI) for mammography, breast-specific gamma imaging (BSGI), and photoacoustic tomography (PT). The latest development in combination imaging is PET/MR, now being introduced by Siemens, Philips, and GE.

This report is intended for industry managers of business development, marketing and engineering; CEOs; venture capital companies; and research and development companies and executives.

To Contact us, click here  

Medical Imaging Technologies for Oncology Diagnostics: The Global Market( HLC074A )
Publish Date: Mar 2011    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.